Literature DB >> 24091697

The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Stephanie M Dillon1, Eric J Lee, Julia M Bramante, Edward Barker, Cara C Wilson.   

Abstract

OBJECTIVE: Natural killer (NK) cells are important in innate immune responses to bacterial and viral pathogens. HIV-1 infection is associated with opportunistic bacterial infections and with microbial translocation, but the nature of the NK cell response to bacteria during HIV-1 infection has not been studied extensively. The objective of this study was to compare NK cell responses to bacteria in HIV-1-infected versus that in uninfected individuals.
METHODS: Multicolor flow cytometry was used to evaluate the ability of blood NK cell subsets (CD56CD16, CD56CD16, and CD56CD16) from treated, virally suppressed, and untreated viremic subjects with chronic HIV-1 infection and uninfected controls, to secrete interferon gamma (IFN-γ) in response to the in vitro stimulation of peripheral blood mononuclear cells with heat-killed commensal Escherichia coli or pathogenic Salmonella typhimurium.
RESULTS: All 3 NK cell subsets produced IFN-γ in response to bacteria, but CD56CD16 NK cells were least responsive. Untreated HIV-1-infected donors had increased frequencies of CD56CD16 NK cells and lower overall frequencies of IFN-γ-producing NK cells responding to E. coli and S. typhimurium than did NK cells from uninfected donors. These NK cell defects were not fully restored in antiretroviral therapy-treated donors. Monocytes were necessary for NK cells to respond to bacteria, but the HIV-associated defect was intrinsic to NK cells because the addition of normal monocytes did not restore IFN-γ production in response to bacteria.
CONCLUSIONS: Functional defects and numeric alterations of NK cell subsets lead to decreased frequencies of bacteria-reactive, IFN-γ-producing NK cells in HIV-1-infected subjects, even those on antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24091697      PMCID: PMC3945425          DOI: 10.1097/01.qai.0000435603.50598.2b

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  81 in total

1.  Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.

Authors:  Galit Alter; Nickolas Teigen; Benjamin T Davis; Marylyn M Addo; Todd J Suscovich; Michael T Waring; Hendrik Streeck; Mary N Johnston; Kyle D Staller; M Tauheed Zaman; Xu G Yu; Mathias Lichterfeld; Nesli Basgoz; Eric S Rosenberg; Marcus Altfeld
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

2.  Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.

Authors:  Veronica D Gonzalez; Karolin Falconer; Niklas K Björkström; Kim G Blom; Ola Weiland; Hans-Gustaf Ljunggren; Annette Alaeus; Johan K Sandberg
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

3.  FimH can directly activate human and murine natural killer cells via TLR4.

Authors:  M Firoz Mian; Nicole M Lauzon; David W Andrews; Brian D Lichty; Ali A Ashkar
Journal:  Mol Ther       Date:  2010-05-04       Impact factor: 11.454

4.  Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation.

Authors:  Gregor F Lichtfuss; Wan-Jung Cheng; Yagmur Farsakoglu; Geza Paukovics; Reena Rajasuriar; Pushparaj Velayudham; Marit Kramski; Anna C Hearps; Paul U Cameron; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

Review 5.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

6.  MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction.

Authors:  Anne Nolting; Anne-Sophie Dugast; Suzannah Rihn; Rutger Luteijn; Mary F Carrington; Katherine Kane; Stephanie Jost; Ildiko Toth; Ellen Nagami; Gerd Faetkenheuer; Pia Hartmann; Marcus Altfeld; Galit Alter
Journal:  Virology       Date:  2010-07-29       Impact factor: 3.616

7.  Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses.

Authors:  Lisbeth N Fink; Louise H Zeuthen; Hanne R Christensen; Barbara Morandi; Hanne Frøkiaer; Guido Ferlazzo
Journal:  Int Immunol       Date:  2007-10-20       Impact factor: 4.823

Review 8.  Acute bacterial infections and HIV disease.

Authors:  C F Gilks
Journal:  Br Med Bull       Date:  1998       Impact factor: 4.291

9.  Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.

Authors:  M R Goodier; N Imami; G Moyle; B Gazzard; F Gotch
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

10.  Activation of human NK cells by the bacterial pathogen-associated molecular pattern muramyl dipeptide.

Authors:  Verónica Athié-Morales; Geraldine M O'Connor; Clair M Gardiner
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

View more
  17 in total

1.  Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report.

Authors:  D J Speicher; V Ramirez-Amador; D P Dittmer; J Webster-Cyriaque; M T Goodman; A-B Moscicki
Journal:  Oral Dis       Date:  2016-04       Impact factor: 3.511

2.  Brief Report: Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation.

Authors:  Stephanie M Dillon; Moriah J Castleman; Daniel N Frank; Gregory L Austin; Sara Gianella; Andrew C Cogswell; Alan L Landay; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-01       Impact factor: 3.731

3.  Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.

Authors:  Jennifer A Juno; Andrew T Stalker; Jillian Lm Waruk; Julius Oyugi; Makobu Kimani; Francis A Plummer; Joshua Kimani; Keith R Fowke
Journal:  Retrovirology       Date:  2015-02-13       Impact factor: 4.602

4.  Impact of HIV infection on the presentation, outcome and host response in patients admitted to the intensive care unit with sepsis; a case control study.

Authors:  Maryse A Wiewel; Michaëla A Huson; Lonneke A van Vught; Arie J Hoogendijk; Peter M C Klein Klouwenberg; Janneke Horn; René Lutter; Olaf L Cremer; Marcus J Schultz; Marc J Bonten; Tom van der Poll
Journal:  Crit Care       Date:  2016-10-10       Impact factor: 9.097

5.  Alterations of the NK cell pool in HIV/HCV co-infection.

Authors:  Dominik J Kaczmarek; Pavlos Kokordelis; Benjamin Krämer; Andreas Glässner; Franziska Wolter; Felix Goeser; Philipp Lutz; Carolynne Schwarze-Zander; Christoph Boesecke; Christian P Strassburg; Jürgen K Rockstroh; Ulrich Spengler; Jacob Nattermann
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

6.  Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.

Authors:  Jon J Kibbie; Stephanie M Dillon; Tezha A Thompson; Christine M Purba; Martin D McCarter; Cara C Wilson
Journal:  Immunobiology       Date:  2021-07-30       Impact factor: 3.152

Review 7.  Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione.

Authors:  Michael Allen; Cedric Bailey; Ian Cahatol; Levi Dodge; Jay Yim; Christine Kassissa; Jennifer Luong; Sarah Kasko; Shalin Pandya; Vishwanath Venketaraman
Journal:  Front Immunol       Date:  2015-10-05       Impact factor: 7.561

8.  Histoplasmosis-Induced Hemophagocytic Syndrome: A Case Series and Review of the Literature.

Authors:  Jennifer Leigh Townsend; Satish Shanbhag; John Hancock; Kathryn Bowman; Ank E Nijhawan
Journal:  Open Forum Infect Dis       Date:  2015-04-15       Impact factor: 3.835

Review 9.  Mucosal immunity in the female genital tract, HIV/AIDS.

Authors:  Juliana Reis Machado; Marcos Vinícius da Silva; Camila Lourencini Cavellani; Marlene Antônia dos Reis; Maria Luiza Gonçalves dos Reis Monteiro; Vicente de Paula Antunes Teixeira; Rosana Rosa Miranda Corrêa
Journal:  Biomed Res Int       Date:  2014-09-15       Impact factor: 3.411

10.  The impact of HIV infection on blood leukocyte responsiveness to bacterial stimulation in asymptomatic patients and patients with bloodstream infection.

Authors:  Michaëla A M Huson; Arie J Hoogendijk; Alex F de Vos; Martin P Grobusch; Tom van der Poll
Journal:  J Int AIDS Soc       Date:  2016-05-16       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.